DNA sequencing

The Chinese Market for DNA Sequencing

Retrieved on: 
Lundi, mai 7, 2018

This report covers the Chinese sequencing market by workflow, including sample preparation products, sequencing instruments and consumables, informatics and sequencing services.

Key Points: 
  • This report covers the Chinese sequencing market by workflow, including sample preparation products, sequencing instruments and consumables, informatics and sequencing services.
  • - An in-depth analysis of the Chinese DNA sequencing market, an important sector in life sciences with enormous market potential
    - Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
    - Quantification of the DNA sequencing market by product type, platform, customer type, value chain position, analysis type, and region
    - A look at the substantial growth opportunities for industry participants, including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments
    - Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
    - Company profiles of major Chinese companies in the sequencing industry, including Gene Denovo, IGE Biotechnology Ltd., Pacific Biosciences, Beijing Genomics Institute (BGI), and Adicon Clinical Laboratories, Inc.
  • - Sequencing companies from major cities such as Beijing, Shanghai and Shenzhen, where the Chinese DNA sequencing industry begun, are now penetrating other Chinese cities.
  • This chapter provides a summary of the Chinese DNA sequencing market.

Next Generation Sequencing (NGS) Global Market 2018-2023 to Grow at a CAGR of 20.21%

Retrieved on: 
Lundi, avril 23, 2018

The "Next generation Sequencing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next generation Sequencing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
  • Next generation sequencing market is projected to expand at a CAGR of 20.21%, to grow from US$4.374 billion in 2017 to US$13.198 billion by 2023.
  • The efficient replacement of traditional technologies (microarrays), cost efficiency, speed and accuracy of technology along with the rise in the application in drug discovery will aid to the global next-generation sequencing demand growth over next five years.
  • However, lack of skilled professionals, interpretation of complex data, and legal and ethical issues are expected to hinder the NGS market growth.

Single-Cell Genome Sequencing Market Worth $2.5 Billion by 2025: Grand View Research, Inc.

Retrieved on: 
Mercredi, avril 18, 2018

The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 14.64% during the forecast period.

Key Points: 
  • The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 14.64% during the forecast period.
  • Moreover, emergence of next-generation sequencing (NGS) has helped the market gain tremendous traction over the past few years.
  • Companies are collaborating with private & public entities as well as academic institutions to accelerate advancements in the single-cell genome sequencing market.
  • Grand View Research has segmented the single-cell genome sequencing market on the basis of products, disease type, and region:
    Single Cell Genome Sequencing Product Type Outlook(Revenue, USD Million, 2014 - 2025)
    Single Cell Genome Sequencing Technology Outlook (Revenue, USD Million, 2014 - 2025)

UNMC, GenomOncology combine to launch first system using HL7 2.5 formatting to transmit discrete genetic data on cancer patients to electronic health record

Retrieved on: 
Mercredi, avril 18, 2018

The system will feed several cancer center output sources with discrete genomic variant data points.

Key Points: 
  • The system will feed several cancer center output sources with discrete genomic variant data points.
  • The data will be fed directly to next-generation sequencing (NGS) panels, the cancer center's research database (called Nebraska Cares), and eventually, into the EHR.
  • In 2015, UNMC cancer center launched GenomOncology's Pathology Workbench to streamline its reporting workflow of NGS of genes to match patients to therapy and clinical trial recommendations.
  • Because of the common internationaltechnologies in the system, Dr. Campbell said it will be compatible with any health system in the country.